{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Ongoing",
      "city": "Best",
      "state": "N/A",
      "country": "Netherlands",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Devices",
      "event_id": "89964",
      "recalling_firm": "PHILIPS MEDICAL SYSTEMS NEDERLAND B.V.",
      "address_1": "Veenpluis 4-6",
      "address_2": "N/A",
      "postal_code": "N/A",
      "voluntary_mandated": "FDA Mandated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "US Nationwide and Worldwide Distribution",
      "recall_number": "Z-0886-2022",
      "product_description": "Azurion systems with software release R1.x",
      "product_quantity": "722 systems",
      "reason_for_recall": "In the Azurion system, the user can add a new study to a patient by selecting the option  Add  Study . The Add Study dialogue box is then displayed where the Patient Type is selected to  perform the study. Due to a software defect, when the study is initiated by pressing  Start  Procedure , the Patient Type changes inadvertently to a Patient Type different than the one  selected as shown in the Table below. Patient type is one of the factors involved in the dose  control process. The incorrect patient type changes the technique factors to be used by the  system without notification to the user.",
      "recall_initiation_date": "20210526",
      "center_classification_date": "20220503",
      "report_date": "20220511",
      "code_info": "software release R1.x"
    }
  ]
}